Delivery Order SPE2DB20D9214-SPE2DB24FD4UT

Award Date 6/17/24
Potential Completion Date 7/10/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,872.20 contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML medical supplies. The order was placed under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which provides medical supplies to support the recurring pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $10,270.50, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order was issued under a $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which runs through December 31, 2025. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,923.32 order is for 4,564,752,921 units of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This delivery order falls under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $7,461.66 order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that runs through December 31, 2025. This IDC allows the DLA to issue firm...
This is a $4,974.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to support the medical supply needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This is a $27,359.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4565029494 - EXPAREL 266 MG/20 ML VIAL 20ML, with a period of performance through July 18, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,436.10 award is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,923.32 order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,556.40 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4UT
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,378.70 order is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military health facilities. The order is placed under a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to fulfill the diverse medical needs of military personnel and their dependents at various Department of Defense (DoD) healthcare facilities. The contract has no set-aside designation.

Generated 9/16/24, 10:54 AM